Skip to main navigation Skip to search Skip to main content

Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment

Research output: Contribution to journalArticlepeer-review

Abstract

Hypoglycemia is a common and feared complication of insulin therapy. As in type 1 and type 2 diabetes, people with cystic fibrosis related diabetes are also at risk for hypoglycemia related to insulin therapy. Spontaneous hypoglycemia is also common in patients with CF without diabetes, who are not on glucose lowering medications. Spontaneous hypoglycemia in CF may also occur during or after an oral glucose tolerance test. In this review, we will discuss the definition, epidemiology, pathophysiology and impact of hypoglycemia, with a focus on people with cystic fibrosis. We will also review strategies to manage and prevent hypoglycemia.

Original languageEnglish (US)
Pages (from-to)S19-S24
JournalJournal of Cystic Fibrosis
Volume18
DOIs
StatePublished - Oct 2019

Bibliographical note

Publisher Copyright:
© 2019 European Cystic Fibrosis Society

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CFRD
  • Cystic fibrosis
  • Hypoglycemia
  • Reactive hypoglycemia

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't
  • Review

Fingerprint

Dive into the research topics of 'Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment'. Together they form a unique fingerprint.

Cite this